Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

AKR1B10 Rabbit anti-Human, Mouse, Rat, Polyclonal, Invitrogen™

Rabbit Polyclonal Antibody

Manufacturer:  Invitrogen PA141259

Catalog No. 01-675-605


Add to cart

Description

Description

AKR1B10, a 316aa protein, catalyzes efficient reduction of aliphatic and aromatic aldehydes. It the first cytosolic NADP (H)-dependent retinal reductase described in humans and is characterized by the presence of a novel NADP binding motif. Due to its ability to convert glucose to sorbitol, AKR1B10 may have a role in development of secondary diabetic complications. It is abundantly expressed in adrenal gland, small intestine and colon, with lower levels in liver, thymus, prostate, testis, and skeletal muscle and its levels are up regulated in certain cancers such as hepatocellular carcinoma.

This antibody is predicted to react with chimpanzee samples based on sequence homology.Suggested positive control: human, mouse or rat liver tissue lysate.
Specifications

Specifications

AKR1B10
Polyclonal
Unconjugated
PBS with 0.2% gelatin and 0.05% sodium azide
O60218
AKR1B10
Rabbit
IgG
100 μg
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Primary
296972, 57016, 67861
Western Blot
0.5 mg/mL
1-3ug/mL
AKR1B10
Liquid
AKR1B10
Synthetic peptide corresponding to residues 100-200 of human AKR1B10.
Protein G
RUO
Antibody
Polyclonal
Human, Mouse, Rat
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit